Dosing antiretroviral medication when crossing time zones: A review: A review

Joe Lewis; Alain Volny-Annec; Catriona Waittd; Marta Boffitoe; Saye Khood

doi:10.1097/qad.0000000000000920

Dosing antiretroviral medication when crossing time zones: A review: A review

Joe Lewis
, Alain Volny-Annec
, Catriona Waittd
, Marta Boffitoe
, Saye Khood

Liverpool University Hospitals NHS Foundation Trust
University of Liverpool
European AIDS Treatment Group
Chelsea and Westminster Foundation Trust

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

International tourism continues to increase worldwide, and people living with HIV and their clinicians are increasingly confronted with the problem of how to dose antiretroviral therapy during transmeridian air travel across time zones. No guidance on this topic currently exists. This review is a response to requests from patient groups for clear, practical and evidence-based guidance for travelling on antiretroviral therapy; we present currently available data on the pharmacokinetic forgiveness and toxicity of various antiretroviral regimens, and synthesize this data to provide guidelines on how to safely dose antiretrovirals when travelling across time zones.

Original language	English
Pages (from-to)	267-271
Number of pages	5
Journal	AIDS
Volume	30
Issue number	2
DOIs	https://doi.org/10.1097/qad.0000000000000920
Publication status	Published - 1 Jan 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antiretroviral
HAART
HIV
Pharmacokinetics
Travel
Travel medicine

Access to Document

10.1097/qad.0000000000000920

Cite this

@article{7906b7b79cd84c94b739007dc526104f,

title = "Dosing antiretroviral medication when crossing time zones: A review: A review",

abstract = "International tourism continues to increase worldwide, and people living with HIV and their clinicians are increasingly confronted with the problem of how to dose antiretroviral therapy during transmeridian air travel across time zones. No guidance on this topic currently exists. This review is a response to requests from patient groups for clear, practical and evidence-based guidance for travelling on antiretroviral therapy; we present currently available data on the pharmacokinetic forgiveness and toxicity of various antiretroviral regimens, and synthesize this data to provide guidelines on how to safely dose antiretrovirals when travelling across time zones.",

keywords = "Antiretroviral, HAART, HIV, Pharmacokinetics, Travel, Travel medicine",

author = "Joe Lewis and Alain Volny-Annec and Catriona Waittd and Marta Boffitoe and Saye Khood",

year = "2016",

month = jan,

day = "1",

doi = "10.1097/qad.0000000000000920",

language = "English",

volume = "30",

pages = "267--271",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Dosing antiretroviral medication when crossing time zones: A review: A review

AU - Lewis, Joe

AU - Volny-Annec, Alain

AU - Waittd, Catriona

AU - Boffitoe, Marta

AU - Khood, Saye

PY - 2016/1/1

Y1 - 2016/1/1

N2 - International tourism continues to increase worldwide, and people living with HIV and their clinicians are increasingly confronted with the problem of how to dose antiretroviral therapy during transmeridian air travel across time zones. No guidance on this topic currently exists. This review is a response to requests from patient groups for clear, practical and evidence-based guidance for travelling on antiretroviral therapy; we present currently available data on the pharmacokinetic forgiveness and toxicity of various antiretroviral regimens, and synthesize this data to provide guidelines on how to safely dose antiretrovirals when travelling across time zones.

AB - International tourism continues to increase worldwide, and people living with HIV and their clinicians are increasingly confronted with the problem of how to dose antiretroviral therapy during transmeridian air travel across time zones. No guidance on this topic currently exists. This review is a response to requests from patient groups for clear, practical and evidence-based guidance for travelling on antiretroviral therapy; we present currently available data on the pharmacokinetic forgiveness and toxicity of various antiretroviral regimens, and synthesize this data to provide guidelines on how to safely dose antiretrovirals when travelling across time zones.

KW - Antiretroviral

KW - HAART

KW - HIV

KW - Pharmacokinetics

KW - Travel

KW - Travel medicine

U2 - 10.1097/qad.0000000000000920

DO - 10.1097/qad.0000000000000920

M3 - Article

SN - 0269-9370

VL - 30

SP - 267

EP - 271

JO - AIDS

JF - AIDS

IS - 2

ER -

Dosing antiretroviral medication when crossing time zones: A review: A review

Abstract

UN SDGs

Keywords

Access to Document

Fingerprint

Cite this